This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2012 Mar 10;30(8):772-4.

doi: 10.1200/JCO.2011.40.2537. Epub 2012 Feb 6.

Wiser use of dose-dense adjuvant therapy in breast cancer

Bruce E Hillner, Thomas J Smith

PMID: 22312107
DOI: 10.1200/JCO.2011.40.2537

Editorial

Wiser use of dose-dense adjuvant therapy in breast cancer

Bruce E Hillner et al. J Clin Oncol. 2012.

. 2012 Mar 10;30(8):772-4.

doi: 10.1200/JCO.2011.40.2537. Epub 2012 Feb 6.

Authors

Bruce E Hillner, Thomas J Smith

PMID: 22312107
DOI: 10.1200/JCO.2011.40.2537

No abstract available

PubMed Disclaimer

Comment in

Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?
Hudis CA, Citron ML, Muss H, Norton L, Winer EP. Hudis CA, et al. J Clin Oncol. 2012 Sep 1;30(25):3148-9; author reply 3149-50. doi: 10.1200/JCO.2012.43.4746. Epub 2012 Jul 30. J Clin Oncol. 2012. PMID: 22851555 No abstract available.

Comment on

Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer.
Hershman DL, Wilde ET, Wright JD, Buono DL, Kalinsky K, Malin JL, Neugut AI. Hershman DL, et al. J Clin Oncol. 2012 Mar 10;30(8):806-12. doi: 10.1200/JCO.2011.37.7499. Epub 2012 Feb 6. J Clin Oncol. 2012. PMID: 22312106 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information